Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G LAWTON

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
BMJ (Clinical Research Ed.)|June 30, 1990
Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smearsD M Luesley, J Cullimore, C W Redman, et al.
FEBS Letters|December 18, 1989
Potent selective inhibitors of protein kinase CP D Davis, C H Hill, E Keech, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1988
Survival following intestinal obstruction in ovarian cancerC W Redman, M I Shafi, S Ambrose, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitorsL Zhang, M A Williams, D B Mendel, et al.
JPRAS Open|March 12, 2020
Microbiological and functional outcomes after open extremity fractures sustained overseas: The experience of a UK level I trauma centreB Ardehali, L Geoghegan, A Khajuria, et al.
Micropublication Biology|February 24, 2025
Genome sequences of three temperate actinobacteriophages from clusters FA and ASJonathan G Lawton, Alyssa D Reddy, Victoria M Herrera, et al.
FEBS Letters|January 9, 1984
New potent inhibitors of angiotensin converting enzymeM R Attwood, R J Francis, C H Hassall, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of ifosfamide in cervical cancerC A Meanwell, J J Mould, G Blackledge, et al.
Journal of Medicinal Chemistry|January 8, 1993
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionR A Bit, P D Davis, L H Elliott, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activityJ S Nixon, J Bishop, D Bradshaw, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
BMJ (Clinical Research Ed.)|June 30, 1990
Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smearsD M Luesley, J Cullimore, C W Redman, et al.
FEBS Letters|December 18, 1989
Potent selective inhibitors of protein kinase CP D Davis, C H Hill, E Keech, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1988
Survival following intestinal obstruction in ovarian cancerC W Redman, M I Shafi, S Ambrose, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Synthesis and evaluation of 1,4,5,6-tetrahydropyridazine derivatives as influenza neuraminidase inhibitorsL Zhang, M A Williams, D B Mendel, et al.
JPRAS Open|March 12, 2020
Microbiological and functional outcomes after open extremity fractures sustained overseas: The experience of a UK level I trauma centreB Ardehali, L Geoghegan, A Khajuria, et al.
Micropublication Biology|February 24, 2025
Genome sequences of three temperate actinobacteriophages from clusters FA and ASJonathan G Lawton, Alyssa D Reddy, Victoria M Herrera, et al.
FEBS Letters|January 9, 1984
New potent inhibitors of angiotensin converting enzymeM R Attwood, R J Francis, C H Hassall, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of ifosfamide in cervical cancerC A Meanwell, J J Mould, G Blackledge, et al.
Journal of Medicinal Chemistry|January 8, 1993
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionR A Bit, P D Davis, L H Elliott, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activityJ S Nixon, J Bishop, D Bradshaw, et al.
Pageof 12